SavedAdd your journal

Journals / Erciyes Tıp Dergisi / 2009 / Cilt: 31 - Sayı: 4

A case of arterial embolism in upper and lower extremities in a patient with factor V leiden mutation and pseudoprotein S deficiency

Faktör V leiden mutasyonu ve psödoprotein S eksikliği olan arteriyel embolizmle seyreden bir olgu

Erdem AKBAL
Mustafa ALTINTAŞ
Dicle KOCA
Pages
344–348
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We are given below a case with arterial thromboembolism in the upper and lower extremities, congestive heart failure, pseudo protein-S deficiency and factor V-Leiden mutation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Thrombosis occurs as a result of factors which is also known as Virchow’s triad.
📊
Key Findings & Data:Virchow’s triad comprises venous stasis, hypercoagulability and endothelial damage.
💡
Conclusion & Impact:We are given below a case with arterial thromboembolism in the upper and lower extremities, congestive heart failure, pseudo protein-S deficiency and factor V-Leiden mutation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Thrombosis occurs as a result of factors which is also known as Virchow’s triad. Virchow’s triad comprises venous stasis, hypercoagulability and endothelial damage. Thromboembolism is mostly due to acquired thrombophilia. However there are a number of hereditary thrombophilias factor V Leiden mutation being the most common among them. Hereditary thrombophilias lead mainly to venous thrombosis and rarely to arterial thrombosis. We are given below a case with arterial thromboembolism in the upper and lower extremities, congestive heart failure, pseudo protein-S deficiency and factor V-Leiden mutation.

Özet

Tromboz Virchow triadı olarak bilinen damar duvarı değişiklikleri, kan akımındaki bozukluklar ve kan yapısındaki değişiklikler sonucu oluşmaktadır. Tromboza eğilim oluşturan durumların çoğu edinseldir. Kalıtsal tromboz nedenlerine ise nadiren rastlanır. Tromboembolik olaylarda en sık rastlanan kalıtsal bozukluk faktör V Leiden mutasyonudur. Kalıtsal risk faktörlerine bağlı komplikasyonlar sıklıkla venöz tromboembolik olaylar olarak gözlenmektedir. Arteriyel tromboembolik olaylara nadiren rastlanır. Bu makalede üst ve alt ekstremitede arteriyel tromboz saptanan, faktör V Leiden mutasyonu ve psödo protein S eksiliği olan bir olgu sunulmuştur.

🔖

Cite This Article

AKBAL, E., ALTINTAŞ, M., KOCA, D. (2022). A case of arterial embolism in upper and lower extremities in a patient with factor V leiden mutation and pseudoprotein S deficiency. Erciyes Tıp Dergisi, Cilt: 31 - Sayı: 4, 344–348. https://ajindex.com/articles/502594

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Dahlback B. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. J Clin Invest 1994; 94:923-927
  2. Oner F, Kaya A, Dogan R, Numanoglu N. Genetic risk factors of venous thromboembolism. Tuberküloz Toraks 2003; 51:60-69
  3. Irdem A, Devecioglu C, Batun S, Soker M, Sucakli IA. Prevalence of factor V Leiden and prothrombin G20210A gene mutation. Saudi Med J 2005;26:580-583
  4. Gurgey A, Mesci L. The prevalence of factor V Leiden (1691 G-->A) mutation in Turkey. Turk J Pediatr 1997; 39: 313-315
  5. Rees DC. The population genetics of factor V Leiden (arg506gln). Br J Haematol 1996; 95:579-586
  6. Donmez Y, Kanadasi M, Tanriverdi K, et al. Prothrombin 20210GA and factor V Leiden mutations in patients less than 55 years old with myocardial infarction. Jpn Heart J 2004; 45:505-512
  7. Bontemto FA, Hassett AC, Faruki H, Steed DL, Webster MW, Makaroun MS. The factor V Leiden mutation: spectrum of trombotic events and laboratory evaluation. J Vasc Surg 1997; 25:271-276
  8. Almawi WY, Tamim H, Kreidy R, et al. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. J Thromb Thrombolysis 2005;19:189-196
  9. Curvers J, Thomassen MC, Rimmer J, et al. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test. Thromb Haemost 2002; 88:5-11
  10. Gemmati D, Serino ML, Verzola I, Mari R, Moratelli S, Ballerini. Resistance to activated protein C and low levels of protein S activity in nine thrombophilic families: a correct diagnosis. Blood Coagul Fibrinolysis. 1997;8:118-123
  11. Dogan Y, Aygun D, Yilmaz Y, et al. Severe protein S deficiency associated with heterozygous factor V Leiden mutation in a child with purpura fulminans. Pediatr Hematol Oncol. 2003;20:1-5.